Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Change in Account Payables (2016 - 2017)

Macrogenics (MGNX) has disclosed Change in Account Payables for 6 consecutive years, with $197000.0 as the latest value for Q2 2017.

  • On a quarterly basis, Change in Account Payables rose 496.97% to $197000.0 in Q2 2017 year-over-year; TTM through Jun 2017 was $561000.0, a 179.91% increase, with the full-year FY2025 number at -$280000.0, up 81.7% from a year prior.
  • Change in Account Payables was $197000.0 for Q2 2017 at Macrogenics, up from -$2.2 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.4 million in Q4 2016 to a low of -$2.7 million in Q4 2014.
  • A 5-year average of -$112611.1 and a median of -$96000.0 in 2015 define the central range for Change in Account Payables.
  • Biggest YoY gain for Change in Account Payables was 496.97% in 2017; the steepest drop was 472.94% in 2017.
  • Macrogenics' Change in Account Payables stood at $1.4 million in 2013, then plummeted by 298.32% to -$2.7 million in 2014, then surged by 61.93% to -$1.0 million in 2015, then surged by 328.5% to $2.4 million in 2016, then plummeted by 91.67% to $197000.0 in 2017.
  • Per Business Quant, the three most recent readings for MGNX's Change in Account Payables are $197000.0 (Q2 2017), -$2.2 million (Q1 2017), and $2.4 million (Q4 2016).